Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: A randomized controlled study

Journal of Hepatology

Volumn 42, Issue 5, 2005, Pages 674-679

  Riggio, O ^a   Masini, A ^a   Efrati, C ^a   Nicolao, F ^a   Angeloni, S ^a   Salvatori, Filippo M ^a   Bezzi, M ^a   Attili, Adolfo F ^a   Merli, M ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Hepatic encephalopathy; Liver cirrhosis; Portal hypertension; TIPS

Indexed keywords

AMMONIA; LACTITOL; RIFAMPICIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FLAPPING TREMOR; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MENTAL HEALTH; MULTIVARIATE ANALYSIS; PATIENT CARE; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; PROPHYLAXIS; PSYCHOLOGIC TEST; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL;

EID: 17044379742     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2004.12.028     Document Type: Article

References (28)

1. M. Rossle, K. Haag, A. Ochs, M. Sellinger, G. Noldge, and J.M. Pernau The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding N Engl J Med 330 1994 165 171
2. J. Cabrera, M. Maynar, R. Granados, E. Gorriz, R. Reyes, and J.M. Pulido-Duque Transjugular intrahepatic portosystemic shunt versus sclerotheraphy in the elective treatment of variceal hemorrage Gastroenterology 110 1996 832 839
3. A.J. Sanjal, A.M. Freedman, V.A. Luketic, P.P. Purdum, H.L. Shiffman, and J. Tisnado Transjugular intrahepatic portosystemic shunts for patients with active variceal hemmorage unresponsive to sclerotheraphy Gastroenterology 111 1996 138 146
4. P. Sauer, L. Theilman, W. Stremmer, C. Benz, G.M. Richter, and A. Stiehl Transjugular intrahepatic portosystemic stent shunt versus sclerotheraphy plus propanolol for variceal rebleeding Gastroenterology 113 1997 1623 1631
5. M. Rossle, P. Deibert, K. Haag, A. Ochs, M. Olschewski, and V. Siegerstetter Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propanolol for prevention of variceal rebleeding Lancet 349 1997 1043 1049
6. M. Merli, F. Salerno, O. Riggio, R. De Franchis, F. Fiaccadori, and P. Meddi Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotheraphy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial Hepatology 27 1998 40 45
7. L. Garcia-Villarreal, F. Martinez-Lagares, A. Sierra, C. Guevara, J.M. Marrero, and E. Jimenez Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotheraphy for the prevention of variceal rebleeding after recent variceal hemorrage Hepatology 29 1999 27 32
8. M. Rossle, A. Ochs, V. Gulberg, V. Siegerstetter, J. Holl, and P. Deibert A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites N Engl J Med 342 2000 1701 1707
9. P. Gines, J. Uriz, B. Calahorra, G. Garcia-Tsao, P.S. Kamath, and L. Ruiz Del Arbol Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin for refractory ascites in cirrhosis Gastroenterology 123 2002 1839 1847
10. A.J. Sanyal, C. Genning, K.R. Reddy, F. Wong, K.V. Kowdley, and K. Benner The North American study for the treatment of refractory ascites Gastroenterology 124 2003 634 641
11. F. Salerno, M. Merli, O. Riggio, M. Cazzaniga, V. Valeriano, and M. Pozzi Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites Hepatology 40 2004 629 635
12. A.J. Sanjal, A. Freedman, M.L. Shiffman, P.P. Purdum, V.A. Luketic, and A.K. Cheatham Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study Hepatology 20 1994 46 55
13. R. Jalan, R.A. Elton, D.N. Redhead, N.D. Finlayson, and P.C. Hayes Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the Transjugular intrahepatic portosystemic shunt for variceal haemorrhage J Hepatol 23 1995 123 128
14. K.A. Somberg, J.L. Riegler, J.M. LaBerge, M.M. Doherty-Simor, P. Bachetti, and J.P. Roberts Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: incidence and risk factors Am J Gastroenterol 90 1995 549 555
15. O. Riggio, M. Merli, R. Pedretti, P. Meddi, R. Lionetti, and P. Rossi Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Incidence and risk factors Dig Dis Sci 41 1996 578 584
16. D.A. Zuckerman, M.D. Darcy, T.P. Bocchini, and C.F. Hildebolt Encephalopathy after transjugular intrahepatic portosystemic shunt: analysis and incidence of potential risk factors Am J Roentgenol 169 1997 1727 1731
17. W. Nolte, J. Wiltfang, C. Schindler, H. Munke, K. Unterberg, and U. Zumhasch Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric and electroencephalographic investigations Hepatology 28 1998 1215 1225
18. O. Riggio, F. Nicolao, S. Angeloni, A. Masini, F. Salvatori, and F. Fanelli Intractable hepatic encephalopathy after TIPS with PTFE-covered stent grafts Scand J Gastroenterol 38 2003 570 572
19. M. Casado, J. Bosch, J.C. Garcia-Pagan, C. Bru, R. Benares, and J.C. Bandi Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings Gastroenterology 114 1998 1296 1303
20. O. Riggio, A. Masini, C. Efrati, and M. Merli TIPS: refractory ascites and hepatic encephalopathy P. Rossi Portal Hypertension 2000 Springer Berlin
21. O. Riggio, G. Balducci, F. Ariosto, M. Merli, U. Pieche, and G. Pinto Lactitol in prevention of recurrent episodes of hepatic encephalopathy in cirrhotic patients with portal systemic shunt Dig Dis Sci 34 1989 823 829
22. O. Riggio, G. Balducci, F. Ariosto, M. Merli, S. Tremiterra, and V. Ziparo Lactitol in the treatment of chronic hepatic encephalopathy: a randomized cross-over comparison with lactulose Hepato-Gastroenterol 37 1990 524 527
23. A. Mas, J. Rodés, L. Rodrigo, R. Planas, V. Vargas, and L. Castells Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a a randomized, double blind, double dummy controlled clinical trial J Hepatol 38 2003 51 58
24. F. Nicolao, C. Efrati, A. Masini, M. Merli, A.F. Attili, and O. Riggio Role of the determination of partial pressure of ammonia in cirrhotic patients with and without hepatic encephalopathy J Hepatol 38 2003 441 446
25. H.O. Conn, C.M. Leevy, Z.R. Vlahcevic, J.B. Rodgers, W.C. Maddrey, and L. Seeff Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial Gastroenterology 72 1977 573 583
26. P. Amodio, H. Wenin, F. Del Piccolo, D. Mapelli, S. Montagnese, and A. Pellegrini Variability of trail making test, symbol digit test and line trait test in normal people. A normative study taking into account age-dependent decline and sociobiological variables Aging Clin Exp Res 14 2002 117 131
27. D. Moher, K.F. Schulz, D. Altman, and CONSORT group The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials J Am Pediatr Med Assoc 91 2001 437 442
28. M.R. Sanaka, J.P. Ong, and K.D. Mullen Challenges of designing hepatic encephalopathy treatment trials Hepatology 38 2003 527 529